Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants.
Herbelin, C
Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants. [electronic resource] - Bone marrow transplantation May 1994 - 563-9 p. digital
Publication Type: Journal Article
0268-3369
Acute Disease
Antibodies, Monoclonal--adverse effects
Bone Marrow Transplantation--adverse effects
Child, Preschool
Drug Resistance
Female
Graft vs Host Disease--therapy
Humans
Infant
Lymphocyte Depletion
Male
Methylprednisolone--therapeutic use
Pilot Projects
Receptors, Interleukin-2--immunology
T-Lymphocytes--immunology
Treatment of steroid-resistant acute graft-versus-host disease with an anti-IL-2-receptor monoclonal antibody (BT 563) in children who received T cell-depleted, partially matched, related bone marrow transplants. [electronic resource] - Bone marrow transplantation May 1994 - 563-9 p. digital
Publication Type: Journal Article
0268-3369
Acute Disease
Antibodies, Monoclonal--adverse effects
Bone Marrow Transplantation--adverse effects
Child, Preschool
Drug Resistance
Female
Graft vs Host Disease--therapy
Humans
Infant
Lymphocyte Depletion
Male
Methylprednisolone--therapeutic use
Pilot Projects
Receptors, Interleukin-2--immunology
T-Lymphocytes--immunology